Gaudium Ivf And Women Health Ltd vs Indegene Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Gaudium IVF and Women Health Ltd is ₹ 105.75 as of 30 Oct 15:30 . The P/E Ratio of Gaudium IVF and Women Health Ltd changed from 21.2 on March 2026 to 21.2 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Indegene Ltd changed from 34 on March 2025 to 26 on March 2026 . This represents a CAGR of -12.55% over 2 years The Market Cap of Gaudium IVF and Women Health Ltd changed from ₹ 519.04 crore on March 2026 to ₹ 519.04 crore on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Indegene Ltd changed from ₹ 13878 crore on March 2025 to ₹ 10469 crore on March 2026 . This represents a CAGR of -13.14% over 2 years The revenue of Gaudium IVF and Women Health Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 20.5 crore. This represent the decline of -100% The revenue of Indegene Ltd for the Sep '26 is ₹ 1137 crore as compare to the Jun '26 revenue of ₹ 1092 crore. This represent the growth of 4.14% The ebitda of Gaudium IVF and Women Health Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 3.55 crore. This represent the decline of -100% The ebitda of Indegene Ltd for the Sep '26 is ₹ 200.7 crore as compare to the Jun '26 ebitda of ₹ 203.2 crore. This represent the decline of -1.23% The net profit of Gaudium IVF and Women Health Ltd changed from ₹ 3.4 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Indegene Ltd changed from ₹ 87.7 crore to ₹ 112.3 crore over 10 quarters. This represents a CAGR of 10.40% The Dividend Payout of Gaudium IVF and Women Health Ltd changed from 47.88 % on March 2023 to 0 % on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Indegene Ltd changed from 26.42 % on March 2025 to 25.54 % on March 2026 . This represents a CAGR of -1.68% over 2 years .

About Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Limited was originally incorporated in the name of 'Gaudium IVF and Women Health Private Limited' as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana.
Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to Gaudium IVF and Women Health Limited', and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center. Company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years.
Gaudium IVF is founded by the Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited.

About Indegene Ltd

Indegene Limited was incorporated as Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad.
Subsequently, name of the Company was changed to Indegene Private Limited' and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016.
Thereafter, Company converted to a Public Company with change in name to Indegene Limited' on November 17, 2022. The Company is a digital-first life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed, precision, and efficiency.
As a specialized company, it combine healthcare domain expertise, fit-for-purpose technology, and an agile operating model to solve the most complex problems in the healthcare industry.

FAQs for the comparison of Gaudium IVF and Women Health Ltd and Indegene Ltd

Which company has a larger market capitalization, Gaudium IVF and Women Health Ltd or Indegene Ltd?

Market cap of Gaudium IVF and Women Health Ltd is 769 Cr while Market cap of Indegene Ltd is 14,161 Cr

What are the key factors driving the stock performance of Gaudium IVF and Women Health Ltd and Indegene Ltd?

The stock performance of Gaudium IVF and Women Health Ltd and Indegene Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gaudium IVF and Women Health Ltd and Indegene Ltd?

As of October 31, 2026, the Gaudium IVF and Women Health Ltd stock price is INR ₹105.75. On the other hand, Indegene Ltd stock price is INR ₹587.65.

How do dividend payouts of Gaudium IVF and Women Health Ltd and Indegene Ltd compare?

To compare the dividend payouts of Gaudium IVF and Women Health Ltd and Indegene Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.